Results 171 to 180 of about 602,595 (256)

Deciphering the full spectrum of Castleman diseases based on a cohort of 700 patients in a western country

open access: yesBritish Journal of Haematology, Volume 208, Issue 6, Page 2036-2046, June 2026.
The spectrum of Castleman diseases has expanded over the past three decades. The phenotype of the diseases varies not only among the three major types but also according to the patient ancestry. Summary Under the Castleman disease (CD) eponym, three distinct diseases sharing common pathological features have been described over time.
Eric Oksenhendler   +4 more
wiley   +1 more source

Disease Association and Diagnosis of Human Herpesvirus 6

open access: yesCanadian Journal of Infectious Diseases, 1994
JM Weber, GAR Wilson
doaj   +1 more source

Human herpesvirus 6-specific T-cell immunity in allogeneic hematopoietic stem cell transplant recipients. [PDF]

open access: yesBlood Adv, 2023
Noviello M   +25 more
europepmc   +1 more source

Repurposing Purine Analog Antivirals to Modulate Serum Uric Acid: Evidence From Real‐World Data

open access: yesClinical and Translational Science, Volume 19, Issue 6, June 2026.
ABSTRACT Xanthine oxidase (XO) inhibitors remain the standard pharmacologic therapy for hyperuricemia. However, additional enzymatic components of the purine degradation pathway may contribute to uric acid synthesis. Guanine deaminase (GD) catalyzes the conversion of guanine to xanthine, providing substrate for downstream oxidation by XO.
Joseph Magagnoli   +5 more
wiley   +1 more source

Therapeutic plasma exchange and extracorporeal membrane oxygenation in the management of fulminant human herpesvirus 6-associated myocarditis and encephalitis. [PDF]

open access: yesWorld J Emerg Med
Culha Hosceylan I   +6 more
europepmc   +1 more source

Chromosome-Specific Human Herpesvirus 6 Integration and Hematologic Malignancies. [PDF]

open access: yesJ Virol, 2022
Heldman MR   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy